Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.

Treatment for Severe Coronavirus Disease 2019 With the Seraph-100 Microbind Affinity Blood Filter

From Critical Care Explorations

The authors sought to determine whether Seraph-100 (Exthera Medical Corporation, Martinez, CA) treatment provides clinical benefit for severe coronavirus disease 2019 cases that require mechanical ventilation and vasopressor support.


Olson SW, Oliver JD, Collen J, et al.  

Estimated Time: 12:23

Categories: Crisis Management, Pulmonary,
Content Type: Articles,